Category: HealthSubscribe via RSS Feed

Pfiser, Moderna shots safe during in vitro fertilisation; healthy gut bacteria may help prevent long COVID

28-Jan-2022 Intellasia | Reuters | 5:02 AM

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified [...] » More

Sinovac regimen gets strong boost from Pfiser, AstraZeneca or J&J COVID shots-study

26-Jan-2022 Intellasia | Reuters | 5:02 AM

A third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfiser-BioNTech or Johnson & Johnson increases antibody levels significantly in those who have previously [...] » More

Pfiser and BioNTech launch trial of Omicron-targeted COVID-19 vaccine

26-Jan-2022 Intellasia | Reuters | 5:02 AM

Pfiser and BioNTech said on Tuesday (January 25) they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 Omicron [...] » More

Dozens of firms to make cheap version of Merck COVID pill for poorer nations

22-Jan-2022 Intellasia | Reuters | 5:02 AM

Nearly 30 generic drugmakers in Asia, Africa and the Middle East will make cheap versions of Merck & Co’s (MRK.N) COVID-19 pill, under a landmark UN-backed deal to [...] » More

Valneva says early studies show COVID-19 vaccine effective against Omicron

21-Jan-2022 Intellasia | Reuters | 5:02 AM

French biotech firm Valneva (VLS.PA) said on Wednesday that preliminary studies showed that three doses of its inactivated COVID-19 vaccine candidate neutralised the Omicron [...] » More

Covid-flu joint booster jab possible late 2023: Moderna

19-Jan-2022 Intellasia | AFP | 5:02 AM

Moderna aims to roll out a combined Covid-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said Monday, hoping a joint jab would encourage people to get an [...] » More

J&J booster 85pct effective against Omicron hospitalisation, S.Africa says

15-Jan-2022 Intellasia | Reuters | 5:02 AM

A Johnson and Johnson COVID-19 vaccine booster shot is 85 percent effective in protecting against being hospitalised by the Omicron variant for 1-2 months after it is [...] » More

WHO warns against treating Covid 19 like flu

13-Jan-2022 Intellasia | Reuters | 7:05 AM

The World Health Organization (WHO) on Tuesday warned against treating COVID-19 as an endemic illness like flu, rather than as a pandemic, saying the spread of the Omicron [...] » More

Half of Europe on track to catch Omicron as China locks down millions

13-Jan-2022 Intellasia | AFP | 7:05 AM

More than half of people in Europe are projected to catch Omicron in the next two months, the WHO said Tuesday, as millions in China faced fresh lockdowns on the two-year [...] » More

Calling Omicron ‘mild’ a mistake, says WHO

08-Jan-2022 Intellasia | AFP | 5:02 AM

The Omicron variant of Covid-19 is killing people across the globe and should not be dismissed as mild, the World Health Organization warned on Thursday. WHO chief Tedros [...] » More

Pandemic may affect infants’ brain development; coronavirus can trigger kidney scarring

08-Jan-2022 Intellasia | Reuters | 5:02 AM

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified [...] » More

CDC advisory panel in favour of Pfiser vaccine booster for ages 12 to 15

06-Jan-2022 Intellasia | Reuters | 4:31 PM

A panel of outside experts advising the US Centers for Disease Control and Prevention (CDC) on Wednesday voted to recommend booster shots of Pfiser Inc (PFE.N) and BioNTech [...] » More

India says safety concerns restricting use of Merck COVID pill

India says safety concerns restricting use of Merck COVID pill

06-Jan-2022 Intellasia | Reuters | 4:30 PM

India has not added Merck’s (MRK.N) COVID-19 pill to its national treatment protocol for the disease due to known safety concerns that have restricted its use [...] » More

Soaring Omicron could lead to more dangerous variants, WHO warns

05-Jan-2022 Intellasia | AFP | 12:24 PM

Soaring Omicron cases around the globe could increase the risk of a newer, more dangerous variant emerging, the World Health Organisation in Europe warned yesterday. While [...] » More

J&J booster slashes Omicron hospitalisations S.African study

J&J booster slashes Omicron hospitalisations S.African study

01-Jan-2022 Intellasia | Reuters | 5:02 AM

A booster dose of Johnson & Johnson Inc’s (JNJ.N) single-dose COVID-19 vaccine was 84 percent effective at preventing hospitalisation in South African healthcare [...] » More